Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients

• Status: Unknown status
• Trial end date: 2020-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

A randomized controlled trial to evaluate whether pretreatment with myo-inositol can lower testosterone levels and improve clinical outcomes in hyperandrogenic PCOS patients undergoing ART

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitair Ziekenhuis Brussel
• Treatments: Folic Acid; Inositol; Vitamin B Complex

Criteria

Inclusion Criteria:

• Women aged 18-40 years

• PCOS phenotypes A, B and C

• Signed informed consent

Exclusion Criteria:

• Other relevant endocrine disorders

• Contraindications to the use of gonadotropins

• Endometriosis grade 3-4

• BMI > 35